ZipRecruiter, Inc. (ZIP): A Bull Case Theory
We came across a bullish thesis on ZipRecruiter, Inc. (ZIP) on Substack by Unemployed Value Degen and Value Don't Lie. In this article, we will summarize the bulls' thesis on ZIP. ZipRecruiter, Inc. (ZIP)'s share was trading at $6.27 as of April 2nd. ZIP's trailing and forward P/E were 34.29 and 31.15 respectively according to Yahoo Finance.
kurhan/Shutterstock.com
ZipRecruiter (ZIP) has undergone a dramatic transformation, experiencing a steep decline in revenue from its 2022 peak of $905 million to $474 million in 2024. This 48% drop is a direct result of the ongoing white-collar hiring slowdown, exacerbated by the tech industry's efficiency-driven cost-cutting and the uncertain impact of AI on employment. Despite this downturn, ZIP remains a key player in the online job marketplace, leveraging its AI-powered job board to create value for both job seekers and employers. While overall hiring demand has slowed, ZIP has strategically focused on deepening its relationships with employers, leading to a significant increase in average spending per customer. Employers who started using ZIP in 2023 are already paying nearly double compared to their 2017 counterparts, showcasing the company's ability to extract more value from its existing user base even amid macroeconomic headwinds.
The core challenge for ZIP is determining whether its revenue decline is a temporary cyclical setback or a more permanent loss of market share. Rough estimates suggest ZIP's market share in the online recruitment space peaked at 10% in 2022 but has since reverted to around 5% in 2024. This leaves open the critical question of whether the decline is primarily due to reduced hiring in ZIP's core industries or whether it is losing ground to competitors like Indeed and LinkedIn. The encouraging sign is that ZIP's most engaged employers continue to spend more, reflecting a sticky customer base that sees value in the platform. If white-collar hiring rebounds and ZIP can regain lost market share, its revenue could easily double from current levels. However, if the slowdown is structural rather than cyclical, ZIP may struggle to return to its previous highs.
Despite the uncertainty, the valuation setup is compelling. ZIP is currently trading at just 1.22x price-to-sales, down from its peak multiple of over 3.0x. A simple return to historical multiples would more than double the stock price, but if revenues also recover, the potential upside becomes far more dramatic. A full return to peak revenue and valuation levels would imply a nearly 4.7x return. In a more aggressive scenario, where ZIP regains its lost employer base and scales further, the upside could reach 11x. The 48% decline in revenue understates the 66% decline in employers using the ZIP platform, and whether ZIP can reclaim this lost ground remains uncertain. However, with a sticky customer base and a strong value proposition, the company is positioned for significant upside if hiring conditions improve. Given the current price of $6.19, the price target for ZIP is between $25 and $64 at some point between 2026 and 2028.
ZipRecruiter, Inc. (ZIP) is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 18 hedge fund portfolios held ZIP at the end of the fourth quarter which was 14 in the previous quarter. While we acknowledge the risk and potential of ZIP as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than ZIP but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock.
Disclosure: None. This article was originally published at Insider Monkey.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
an hour ago
- Business Upturn
IOVA FRAUD ALERT: Iovance Biotherapeutics Investors are Reminded of Ongoing Securities Fraud Class Action — Contact BFA Law by July 14 Legal Deadline (NASDAQ:IOVA)
NEW YORK, June 22, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Iovance you are encouraged to obtain additional information by visiting Investors have until July 14, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased Iovance securities. The case is pending in the U.S. District Court for the Northern District of California and is captioned Sundaram v. Iovance Biotherapeutics, Inc., et al. , No. 25-cv-04177. Why was Iovance Sued for Securities Fraud? Iovance is a commercial-stage biopharmaceutical company focused on the development of treatments for melanoma and other solid tumor cancers. The Company commercially launched its key melanoma treatment Amtagvi in February 2024. Iovance administers Amtagvi at the Company's authorized treatment centers ('ATCs'). As alleged, Iovance repeatedly touted its ATCs as a driver of demand for Amtagvi. In truth, Iovance's ATCs were experiencing long timelines to begin treating patients with Amtagvi, and ineffective patient identification and patient selection for treatment was causing high patient drop-offs at the ATCs. The Stock Declines as the Truth is Revealed On May 8, 2025, Iovance reported disappointing financial results for 1Q25 and announced it was 'revising full-year 2025 revenue guidance.' The Company blamed 'recent launch dynamics,' including slow 'treatment timelines for new ATCs' and 'the variable pace at which ATCs began treating patients,' which 'differs from center to center.' Iovance also blamed the poor results on high 'patient drop-off' due to inadequate 'patient selection' for treatment. On this news, the price of Iovance stock declined more than 44%, from $3.17 per share on May 8, 2025, to $1.75 per share on May 9, 2025. Click here if you suffered losses: What Can You Do? If you invested in Iovance you may have legal options and are encouraged to submit your information to the firm. All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses. Submit your information by visiting: Or contact:Ross Shikowitz [email protected] 212-789-3619
Business Upturn
an hour ago
- Business Upturn
FTRE FRAUD ALERT: Fortrea Holdings Inc. Investors are Reminded of Ongoing Securities Fraud Class Action — Contact BFA Law by August 1 Legal Deadline (NASDAQ:FTRE)
NEW YORK, June 22, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Fortrea Holdings Inc. (NASDAQ: FTRE) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Fortrea you are encouraged to obtain additional information by visiting Investors have until August 1, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased Fortrea securities. The case is pending in the U.S. District Court for the Southern District of New York and is captioned Deslande v. Fortrea Holdings Inc., et al. , No. 1:25-cv-04630. Why was Fortrea Sued for Securities Fraud? Fortrea is a global contract research organization that provides biopharmaceutical product and medical device development solutions. In June 2023, Fortrea was spun off into a standalone, publicly traded company by Labcorp Holdings Inc. ('Labcorp'). In connection with the spin-off, Fortrea entered into several transition services agreements (the 'TSAs'), pursuant to which it agreed to pay Labcorp for certain transitional services over a set period. As alleged, Fortrea discussed the significant cost savings and margin improvements that would result from exiting the TSAs. In truth, Fortrea overstated the cost savings and margin improvement it would achieve by exiting the TSAs, as well as the amount of revenue it would generate from pre-spin projects. The Stock Declines as the Truth is Revealed On September 25, 2024, investment bank Jefferies published a report stating that the cost savings Fortrea would achieve from exiting the TSAs were '[n]ot as [m]aterial as [o]ne [m]ight [t]hink.' On this news, the price of Fortrea stock declined $2.73 per share, or over 12%, from a closing price of $22.21 per share on September 24, 2024, to $19.48 per share on September 25, 2024. Then, on March 3, 2025, Fortrea announced disappointing Q4 and full year 2024 financial results, revealing that the company's pre-spin projects 'have less revenue and less profitability than expected for 2025' and that 'post-spin work is not coming on fast enough to offset the pre-spin contract economics.' On this news, the price of Fortrea stock declined $3.47 per share, or over 25%, from a closing price of $13.85 per share on February 28, 2025, to $10.38 per share on March 3, 2025, the next trading day. Click here if you suffered losses: What Can You Do? If you invested in Fortrea you may have legal options and are encouraged to submit your information to the firm. All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses. Submit your information by visiting: Or contact:Ross Shikowitz [email protected] 212-789-3619
Yahoo
4 hours ago
- Yahoo
Homebuyer Sees What The House Sold For 5 Years Ago And Can't Believe Today's Price: 'Does Anybody Else Have Trouble Swallowing These Prices'
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. A Reddit user trying to buy a home opened up about the frustration of seeing how much the same house sold for just five years ago. The post struck a nerve, sparking a wave of responses from people venting about the state of the housing market. The original poster explained in the r/RealEstate subreddit that they were finally ready to buy after years of renting, largely due to an ongoing lawsuit involving a prior land purchase. They had bought acreage that turned out to be a landfill—something that wasn't disclosed at the time of sale, prompting the legal battle. Don't Miss: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — Peter Thiel turned $1,700 into $5 billion—now accredited investors are eyeing this software company with similar breakout potential. Learn how you can They now found a nearly perfect home for their situation but were shocked to see that the price had nearly doubled since it last sold. 'It just pains me to see a house be so up in value just a few years ago and makes me question everything,' they wrote. That comment captured a widespread feeling. Many others shared that they, too, had a tough time seeing homes that sold for far less not that long ago now being listed at eye-popping prices. One person responded, 'I struggled with it for many years and it just got worse. I finally just bought another house and try not to think about it.' Trending: Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. Many Redditors pointed to inflation, low pandemic-era interest rates, and wage stagnation as key reasons prices have surged. Some mentioned the psychological concept of 'anchoring,' where people get stuck on past prices and can't adjust to current values. 'You aren't trying to buy a house five years ago, so no point looking at that and wishing,' one person wrote. 'Buy a house you can afford when it fits your life.' Still, plenty sympathized with OP's situation. Some described feeling priced out altogether, especially younger or first-time buyers. 'There are two classes of people,' one person wrote. 'Pre-pandemic buyers, who essentially won the lottery, and those who didn't own before the pandemic, who were basically left for dead.' , The thread revealed a split in thinking. Some say now is the best time to buy since no one can time the market. Others believe prices will eventually come down, especially in areas where homes are sitting longer. 'Housing may ebb and flatten, but it rarely goes back down,' one person noted. A few people also raised concerns about corporate investors buying homes in bulk and turning them into rentals, putting even more pressure on everyday buyers. 'It's not just houses, it's everything,' someone else added. Groceries, cars, insurance. The dollar just doesn't go as far anymore. Still, despite the frustration, many advised the OP to focus less on past prices and more on whether the current home meets their needs and budget. As one commenter put it: If it checks the boxes and you can afford it, go for it. There's always going to be a reason to wait. Read Next: With Point, you can This Jeff Bezos-backed startup will allow you to .This article Homebuyer Sees What The House Sold For 5 Years Ago And Can't Believe Today's Price: 'Does Anybody Else Have Trouble Swallowing These Prices' originally appeared on
